Poets | Bookstore | Poem of the Day | Top 40 | Search | Comments | Privacy
April 18th, 2014 - we have 234 poets, 8,025 poems and 103,948 comments.
Analysis and comments on Never Try To Trick Me With A Kiss by Sylvia Plath

1 2 3 4 5 [6] 7 8 9 10

Comment 47 of 97, added on July 4th, 2013 at 11:34 AM.
QVmKVTDspSHZjcapzQ

c4073I Thanks-a-mundo for the blog post.Really looking forward to read
more. Keep writing.

news and many more from Ireland
Comment 46 of 97, added on July 4th, 2013 at 9:35 AM.
NVLcAlZRKHNZRMToZnl

BUlsfT I loved your blog. Fantastic.

news and many more from Croatia
Comment 45 of 97, added on July 4th, 2013 at 8:43 AM.
yuCahpLYUYTJcH

hipiyA This is one awesome article. Really Cool.

news and many more from Uganda
Comment 44 of 97, added on June 19th, 2013 at 4:36 PM.
DXNfdFEoDNznDwuT

S82LkY I really enjoy the article post.Really looking forward to read more.
Really Great.

social bookmarks from Qatar
Comment 43 of 97, added on May 28th, 2013 at 7:22 AM.
yHRfDjBhXRZizkgwU

ro1Ami I value the article post. Awesome.

seo service from Zambia
Comment 42 of 97, added on May 27th, 2013 at 4:14 PM.
LDPyssgsjwdHhmZI

VZE7lj wow, awesome blog article. Really Cool.

seo service from Antigua and Barbuda
Comment 41 of 97, added on May 27th, 2013 at 3:59 PM.
xoozKzfDfcrldXscRpe

jaSlVr This is one awesome blog.Really looking forward to read more. Really
Great.

seo service from Bulgaria
Comment 40 of 97, added on May 27th, 2013 at 10:51 AM.
OVfpmNRGaocTOwKCLkp

edlXi4 I appreciate you sharing this blog article.Really thank you!
Awesome.

seo service from United States
Comment 39 of 97, added on May 27th, 2013 at 8:39 AM.
MstGqwhRAoUAymSMyC

YZveEw Say, you got a nice article post.Much thanks again. Want more.

seo service from Palestine
Comment 38 of 97, added on May 26th, 2013 at 3:04 AM.
Updated: Midland labor market adds 1000 jobs in April bcp

The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223
dichloride) to treat men with symptomatic late-stage (metastatic)
castration-resistant prostate cancer that has spread to bones but not to
other organs. It is intended for men whose cancer has spread after
receiving medical or surgical therapy to lower testosterone.

Prostate cancer forms in a gland in the male reproductive system found
below the bladder and in front of the rectum. The male sex hormone
testosterone stimulates the prostate tumors to grow. According to the
National Cancer Institute, an estimated 238,590 men will be diagnosed with
prostate cancer and 29,720 will die from the disease in 2013.

Xofigo is being approved more than three months ahead of the product¡¯s
prescription drug user fee goal date of Aug. 14, 2013, the date the agency
was scheduled to complete review of the drug application. The FDA reviewed
Xofigo under the agency¡¯s priority review program, which provides for an
expedited review of drugs that appear to provide safe and effective therapy
when no satisfactory alternative therapy exists, or offer significant
improvement compared to marketed products.

¡°Xofigo binds with minerals in the bone to deliver radiation directly to
bone tumors, limiting the damage to the surrounding normal tissues,¡± said
Richard Pazdur, M.D., director of the Office of Hematology and Oncology
Products in the FDA¡¯s Center for Drug Evaluation and Research. ¡°Xofigo is
the second prostate cancer drug approved by the FDA in the past year that
demonstrates an ability to extend the survival of men with metastatic
prostate cancer.¡±

In August 2012, the FDA approved Xtandi to treat men with metastatic
castration-resistant prostate cancer that has spread or recurred, even with
medical or surgical therapy to minimize testosterone. Xtandi is approved
for patients who have previously been treated the chemotherapy drug
docetaxel.

Xofigo¡¯s safety and effectiveness were evaluated in a single clinical
trial of 809 men with symptomatic castration-resistant prostate cancer that
spread to bones but not to other organs. Patients were randomly assigned to
receive Xofigo or a placebo plus best standard of care.

The study was designed to measure overall survival. Results from a
pre-planned interim analysis showed men receiving Xofigo lived a median of
14 months compared to a median of 11.2 months for men receiving placebo. An
exploratory updated analysis conducted later in the trial confirmed
Xofigo¡¯s ability to extend overall survival.

The most common side effects reported during clinical trials in men
receiving Xofigo were nausea, diarrhea, vomiting and swelling of the leg,
ankle or foot. The most common abnormalities detected during blood testing
included low levels of red blood cells (anemia), lymphocytes
(lymphocytopenia), white blood cells (leukopenia), platelets
(thrombocytopenia) and infection-fighting white blood cells (neutropenia).




gandigoBligma from Romania

This poem has been commented on more than 10 times. Click below to see the other comments.
1 2 3 4 5 [6] 7 8 9 10
Share |


Information about Never Try To Trick Me With A Kiss

Poet: Sylvia Plath
Poem: Never Try To Trick Me With A Kiss
Added: Feb 20 2003
Viewed: 27484 times


Add Comment

Do you have any comments, criticism, paraphrasis or analysis of this poem that you feel would assist other visitors in understanding this poem better? If they are accepted, they will be added to this page of American Poems. Together we can build a wealth of information, but it will take some discipline and determination.

Do not post questions, pleas for homework help or anything of the sort, as these types of comments will be removed. The proper place for questions is the poetry forum.

Please note that after you post a comment, it can take up to an hour before it is visible on the website! Rest assured that your comment is not lost, so don't enter your comment again.

Comment on: Never Try To Trick Me With A Kiss
By: Sylvia Plath

Name: (required)
E-mail Address: (required)
Country:
Show E-mail Address:
Yes No
Subject:
Poem Comments:

Poem Info

Plath Info
Copyright © 2000-2012 Gunnar Bengtsson. All Rights Reserved. Links | Bookstore